atropine: be administered with neostigmine

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.66
, alkaloid
Weight: 0.59
, agent
Weight: 0.57
, substance
Weight: 0.55
, medicine
Weight: 0.51
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.35
, morphine
Weight: 0.35
, metronidazole
Weight: 0.35

Related properties

Property Similarity
be administered with neostigmine 1.00
be given with neostigmine 0.91
is administered 0.90
is administered preoperatively 0.87
be given for bradycardia 0.75
be given before irinotecan 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.71
Similarity weight: 1.00
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.51
¬ Salient(atropine, be administered with neostigmine)

Similarity expansion

0.74
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.90
Evidence: 0.42
Typical(atropine, be administered with neostigmine) ⋁
Evidence: 0.05
¬ Typical(atropine, is administered)
0.68
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.90
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.20
¬ Plausible(atropine, is administered)
0.63
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.87
Evidence: 0.67
Remarkable(atropine, be administered with neostigmine) ⋁
Evidence: 0.45
¬ Remarkable(atropine, is administered preoperatively)
0.61
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.90
Evidence: 0.51
Salient(atropine, be administered with neostigmine) ⋁
Evidence: 0.41
¬ Salient(atropine, is administered)
0.60
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.91
Evidence: 0.67
Remarkable(atropine, be administered with neostigmine) ⋁
Evidence: 0.69
¬ Remarkable(atropine, be given with neostigmine)
0.59
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.75
Evidence: 0.67
Remarkable(atropine, be administered with neostigmine) ⋁
Evidence: 0.24
¬ Remarkable(atropine, be given for bradycardia)
0.59
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.87
Evidence: 0.51
Salient(atropine, be administered with neostigmine) ⋁
Evidence: 0.42
¬ Salient(atropine, is administered preoperatively)
0.55
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.87
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.45
¬ Plausible(atropine, is administered preoperatively)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.75
Evidence: 0.51
Salient(atropine, be administered with neostigmine) ⋁
Evidence: 0.31
¬ Salient(atropine, be given for bradycardia)
0.54
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.90
Evidence: 0.67
Remarkable(atropine, be administered with neostigmine) ⋁
Evidence: 0.91
¬ Remarkable(atropine, is administered)
0.53
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.75
Evidence: 0.67
Remarkable(atropine, be administered with neostigmine) ⋁
Evidence: 0.52
¬ Remarkable(atropine, be given before irinotecan)
0.53
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.91
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.58
¬ Plausible(atropine, be given with neostigmine)
0.52
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.91
Evidence: 0.51
Salient(atropine, be administered with neostigmine) ⋁
Evidence: 0.68
¬ Salient(atropine, be given with neostigmine)
0.52
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.91
Evidence: 0.42
Typical(atropine, be administered with neostigmine) ⋁
Evidence: 0.58
¬ Typical(atropine, be given with neostigmine)
0.52
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.87
Evidence: 0.42
Typical(atropine, be administered with neostigmine) ⋁
Evidence: 0.52
¬ Typical(atropine, is administered preoperatively)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.75
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.43
¬ Plausible(atropine, be given for bradycardia)
0.40
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.75
Evidence: 0.42
Typical(atropine, be administered with neostigmine) ⋁
Evidence: 0.65
¬ Typical(atropine, be given for bradycardia)
0.37
Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.75
Evidence: 0.51
Salient(atropine, be administered with neostigmine) ⋁
Evidence: 0.87
¬ Salient(atropine, be given before irinotecan)
0.34
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.75
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.84
¬ Plausible(atropine, be given before irinotecan)
0.31
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.75
Evidence: 0.42
Typical(atropine, be administered with neostigmine) ⋁
Evidence: 0.90
¬ Typical(atropine, be given before irinotecan)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.51
Salient(atropine, be administered with neostigmine) ⋁
Evidence: 0.42
¬ Typical(atropine, be administered with neostigmine) ⋁
Evidence: 0.67
¬ Remarkable(atropine, be administered with neostigmine)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.44
Plausible(atropine, be administered with neostigmine) ⋁
Evidence: 0.42
¬ Typical(atropine, be administered with neostigmine)